Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Rev Gastroenterol Mex (Engl Ed) ; 89(3): 418-441, 2024.
Artigo em Inglês | MEDLINE | ID: mdl-39003101

RESUMO

INTRODUCTION: Management of the patient with cirrhosis of the liver that requires surgical treatment has been relatively unexplored. In Mexico, there is currently no formal stance or expert recommendations to guide clinical decision-making in this context. AIMS: The present position paper reviews the existing evidence on risks, prognoses, precautions, special care, and specific management or procedures for patients with cirrhosis that require surgical interventions or invasive procedures. Our aim is to provide recommendations by an expert panel, based on the best published evidence, and consequently ensure timely, quality, efficient, and low-risk care for this specific group of patients. RESULTS: Twenty-seven recommendations were developed that address preoperative considerations, intraoperative settings, and postoperative follow-up and care. CONCLUSIONS: The assessment and care of patients with cirrhosis that require major surgical or invasive procedures should be overseen by a multidisciplinary team that includes the anesthesiologist, hepatologist, gastroenterologist, and clinical nutritionist. With respect to decompensated patients, a nephrology specialist may be required, given that kidney function is also a parameter involved in the prognosis of these patients.


Assuntos
Cirrose Hepática , Assistência Perioperatória , Humanos , Cirrose Hepática/complicações , Cirrose Hepática/cirurgia , Assistência Perioperatória/métodos , Assistência Perioperatória/normas , México , Complicações Pós-Operatórias/prevenção & controle
2.
Rev Gastroenterol Mex (Engl Ed) ; 88(2): 155-174, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37127462

RESUMO

The first clinical guidelines on hepatic encephalopathy were published in 2009. Almost 14 years since that first publication, numerous advances in the field of diagnosis, treatment, and special condition care have been made. Therefore, as an initiative of the Asociación Mexicana de Gastroenterología A.C., we present a current view of those aspects. The manuscript described herein was formulated by 24 experts that participated in six working groups, analyzing, discussing, and summarizing the following topics: Definition of hepatic encephalopathy; recommended classifications; epidemiologic panorama, worldwide and in Mexico; diagnostic tools; conditions that merit a differential diagnosis; treatment; and primary and secondary prophylaxis. Likewise, these guidelines emphasize the management of certain special conditions, such as hepatic encephalopathy in acute liver failure and acute-on-chronic liver failure, as well as specific care in patients with hepatic encephalopathy, such as the use of medications and types of sedation, describing those that are permitted or recommended, and those that are not.


Assuntos
Encefalopatia Hepática , Lactulose , Rifaximina , Encefalopatia Hepática/diagnóstico , Encefalopatia Hepática/tratamento farmacológico , Rifaximina/uso terapêutico , Lactulose/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA